tiprankstipranks
Immunome, Inc. (IMNM)
:IMNM
US Market

Immunome (IMNM) Income Statement

Compare
255 Followers

Immunome Income Statement

Last quarter (Q3 2024), Immunome's total revenue was $2.91M, a decrease of -18.37% from the same quarter last year. In Q3, Immunome's net income was $-47.10M. See Immunome’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 14.02M$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -8.91M$ -631.00K$ -755.00K$ -755.00K$ -615.00K
Operating Expenses
$ 122.82M$ 36.90M$ 25.20M$ 12.26M$ 10.35M
Depreciation and Amortization
$ 728.00K$ 631.00K$ 755.00K$ 755.00K$ 615.00K
EBITDA
$ -28.27M$ -36.27M$ -23.95M$ -17.04M$ -9.72M
Operating Income
$ -109.53M$ -36.90M$ -25.20M$ -12.26M$ -10.35M
Other Income/Expenses
$ 2.72M$ 5.00K$ 493.00K$ -5.58M$ -96.00K
Pretax Income
$ -106.81M$ -36.90M$ -24.71M$ -17.84M$ -10.44M
Net Income
$ -106.81M$ -37.51M$ -24.47M$ -17.12M$ -10.55M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -5.38$ -3.09$ -2.12$ -1.69$ -1.84
Diluted EPS
$ -5.38$ -3.09$ -2.12$ -1.69$ -1.84
Weighted Average Shares Outstanding
19.84M 12.13M 11.54M 10.11M 5.74M
Weighted Average Shares Outstanding (Diluted)
19.84M 12.13M 11.54M 10.11M 5.74M
Currency in USD

Immunome Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis